Similarly, treatment of obese/diabetic mice with metformin during EO771 tumor growth resulted in reduced tumor growth rates with less aligned collagen, decreased vascularity, reduced numbers of CD206+ TAM, and diminished pulmonary metastasis [239]. This evidence concerns the gene MRC1 and neoplasm.